EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudieOpen Access · CC BY-NC 4.0

Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single‐Center Cohort Study

Blas Holger Mogensen, Torsten Holm Nielsen, Mette Ølgod Pedersen, Lise Mette Rahbek Gjerdrum, Tarec Christoffer El-Galaly, Lars Møller Pedersen iD

European Journal of Haematology · 2026

DOI: 10.1111/ejh.70045 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Blas Holger Mogensen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zealand University Hospital, Roskilde, Denmark. Hauptthemen laut MEDLINE: Lymphoproliferative Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the diagnostic evaluation of suspected lymphoma, both core needle biopsy (CNB) and surgical excisional biopsy (SEB) are routinely employed for tissue sampling. While SEB remains the gold standard, CNB is a less invasive and more cost‐effective alternative. However, concerns persist regarding its diagnostic yield. This study aimed to assess the diagnostic performance of CNB in comparison to SEB in routine clinical practice. We included 179 patients with newly diagnosed lymphoma referred to Zealand University Hospital in 2023, of whom 84 underwent CNB based on PET/CT findings. A definitive lymphoma diagnosis was established in 74% of CNB cases, compared to 98% with SEB, underscoring a lower diagnostic yield of CNB. The diagnostic accuracy of CNB varied by biopsy location, lymphoma subtype, and the volume of tissue obtained. Inconclusive diagnoses were more frequent in indolent lymphoma subtypes, biopsies yielding a limited number of tissue cylinders, and samples taken from the axillary and inguinal regions or extranodal sites. Grade 3–4 complications were observed in 1% of CNBs and in 5% of SEBs. Although CNB was a safe procedure, further refinement of biopsy techniques and improved patient selection are needed to enhance its diagnostic accuracy and clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoproliferative DisordersHumansBiopsy, Large-Core NeedleMaleFemaleMiddle AgedAgedAdultAged, 80 and overPositron Emission Tomography Computed TomographyLymphomaYoung Adult

Stichwörter der Autor:innen

core needle biopsylymphomasurgical excision biopsy

Autor:innen und Institutionen

  • Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Danish Medicines Agency, Copenhagen, Denmark.
  • Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Lars Møller Pedersen

Zitieren

APA

Mogensen, B. H., Nielsen, T. H., Pedersen, M. Ø., Gjerdrum, L. M. R., El-Galaly, T. C., & Pedersen, L. M. (2026). Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single‐Center Cohort Study. European Journal of Haematology. https://doi.org/10.1111/ejh.70045

Vancouver

Mogensen BH, Nielsen TH, Pedersen MØ, Gjerdrum LMR, El-Galaly TC, Pedersen LM. Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single‐Center Cohort Study. European Journal of Haematology. 2026. doi:10.1111/ejh.70045

BibTeX
@article{Mogensen2026,
  author = {Mogensen, Blas Holger and Nielsen, Torsten Holm and Pedersen, Mette Ølgod and Gjerdrum, Lise Mette Rahbek and El-Galaly, Tarec Christoffer and Pedersen, Lars Møller},
  title = {Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single‐Center Cohort Study},
  journal = {European Journal of Haematology},
  year = {2026},
  doi = {10.1111/ejh.70045}
}
Kostenlos starten →